# AstraZeneca completes divestment agreement with Atnahs Pharma

- Link: https://www.directorstalkinterviews.com/astrazeneca-completes-divestment-agreement-with-atnahs-pharma/412807168
- Published: 2020-03-02T07:28:56+00:00
- Author: Amilia Stone

**AstraZeneca **([LON:AZN](https://www.directorstalkinterviews.com/ftse-company/astrazeneca/azn.l))
today announced that it has completed the previously communicated agreement with
Atnahs Pharma to divest its global commercial rights to _Inderal_ (propranolol),
_Tenormin _(atenolol), _Tenoretic_ (atenolol, chlorthalidone fixed-dose combination),
_Zestril_ (lisinopril) and _Zestoretic_ (lisinopril, hydrochlorothiazide fixed-dose
combination).

**_Financial considerations_**

Under the terms of the agreement, AstraZeneca has received a payment of $350m from
Atnahs. The Company may also receive future sales-contingent payments of up to $
40m between 2020 and 2022. The upfront payment will be reported in AstraZeneca’s
financial statements within Other Operating Income & Expense in the first quarter
of 2020.

**_Inderal_**

_Inderal_ (propranolol) is a beta-blocker and is predominantly used to treat tremors,
angina, hypertension, arrhythmias, and other heart or circulatory conditions. It
is also used to reduce the severity and frequency of migraine.

**_Tenormin_**** and _Tenoretic_**

_Tenormin_ (atenolol) is a beta-blocker that is used to treat angina and hypertension,
as well as certain kinds of arrhythmias. It is also used to lower the risk of death
after a heart attack. _Tenoretic_ is a fixed-dose combination of atenolol (beta-
blocker) and chlorthalidone (diuretic), used to treat high blood pressure.

**_Zestril_**** and _Zestoretic_**

_Zestril_ (lisinopril) is an angiotensin-converting enzyme (ACE) inhibitor used 
to treat hypertension, congestive heart failure, diabetic-related conditions and
hypertensive renal disease. _Zestril_ may also be used to improve survival after
a heart attack. _Zestoretic_ is a fixed-dose combination of lisinopril (ACE inhibitor)
and hydrochlorothiazide (diuretic) used to treat hypertension.

**_AstraZeneca_**

AstraZeneca is a global, science-led biopharmaceutical company that focuses on the
discovery, development and commercialisation of prescription medicines, primarily
for the treatment of diseases in three therapy areas – Oncology, Cardiovascular,
Renal and Metabolism, and Respiratory. Based in Cambridge, UK, AstraZeneca operates
in over 100 countries and its innovative medicines are used by millions of patients
worldwide. 

Share on:
